Dr. Bacel Nseir, MD

Dr. Nseir practices at Houston Methodist Hospital in Houston, Texas, part of Houston Methodist.

Dr. Nseir's NPI, 1265616858, was assigned on December 19, 2007. Dr. Nseir graduated from Tishreen Unversity in 2001. Dr. Nseir holds Texas license Q1250.

Dr. Nseir's primary practice is Houston Methodist Hospital, at 6565 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 790-2221.

Dr. Nseir's primary practice is Houston Methodist Hospital in Houston, Texas, part of Houston Methodist. Dr. Nseir is also affiliated with Texas Orthopedic Hospital. The medical group on file is CLS Health. Dmand AI also links Dr. Nseir to 3 more group practices and clinics, 2 medical groups and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nseir practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Nseir's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Nseir is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Nseir's licenses on file in 4 states: Texas, Arizona, Louisiana and Ohio.

Dmand AI lists acute skin infection, pneumonia and UTI among the conditions Dr. Nseir treats.

CMS data shows 3,490 Medicare services from Dr. Nseir across 5 procedure codes in 2024, for 460 Medicare patients. Medicare paid $321,330 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 460 Medicare patients who saw Dr. Nseir in 2024. The largest group is 75 to 84, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 4.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nseir's median patient age at 70, with 52% women.

In 2024, Dr. Nseir wrote 212 Medicare Part D claims for 99 patients. 98% of them were for generic drugs. CMS names the drug for 150 of them, across 7 drugs with 11 or more claims each, at $56,072 in total drug cost. In 2023, CMS named 138 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nseir for performance year 2024, reported individually. Dr. Nseir accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Nseir. Dr. Nseir's most frequent co-author is Anthony F. Cutrona.

CMS Open Payments shows 32 general payments to Dr. Nseir from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Janssen Pharmaceuticals, Inc paid the most, $260.

Dr. Nseir graduated from Tishreen Unversity in 2001. Dr. Nseir is a member of American Association for the Study of Liver Diseases (AASLD) and IDSA.

Dr. Nseir is in network with 23 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.